50 years ago, my colleagues and I pursued basic research science that became revolutionary
Featured in STAT
50 years ago, my colleagues and I pursued basic research science that became revolutionary
When we found interleukin-2, we didn’t know it would be critical to HIV, cancer treatment, and more
By Robert C. Gallo, Oct. 9, 2026.
We are pleased to share a new commentary by Robert C. Gallo, MD, GVN co-founder and international scientific director, published today in STAT, a leading health and medicine news publication. Dr. Gallo is also founding director of the University of South Florida’s Institute for Translational Virology & Innovation, a GVN Center of Excellence, and director of the microbial oncology program at the Tampa General Hospital Cancer Institute.
In the commentary, Dr. Gallo reflects on the 50th anniversary of the discovery of interleukin-2 (IL-2), its far-reaching impact on medicine, and the critical importance of basic science in driving breakthrough discoveries.
We encourage you to read and share the commentary with your colleagues and professional networks.